FDA NDC Directory · JSON-LD · Markdown

Myrbetriq

NDC 0469-5020 · HUMAN PRESCRIPTION DRUG · GRANULE, FOR SUSPENSION, EXTENDED RELEASE

Generic namemirabegron
Labeler / ManufacturerAstellas Pharma US, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA213801
Dosage form / routeGRANULE, FOR SUSPENSION, EXTENDED RELEASE · ORAL
Active ingredientsMIRABEGRON (8 mg/mL)
Marketing started20210325
Package count1

External sources

Source: openFDA. Public-domain (CC0).